Keyphrases
Advanced Ovarian Cancer
31%
Advanced Stage
26%
Apoptosis
15%
Cancer Patients
17%
Cancer Stage
25%
Cancer Stem Cells
15%
Carbohydrate Antigen 125 (CA125)
38%
Carboplatin-paclitaxel
15%
Cervical Cancer
100%
Cervical Cancer Patients
41%
Chemotherapy
45%
Cisplatin
16%
Diagnostic Challenge
15%
Endometriosis
27%
Epithelial Ovarian Cancer
68%
General Hospital
15%
Gynecological Cancer
30%
Human Tissue Kallikrein
15%
Immune Checkpoint Inhibitors
15%
Indonesia
85%
Indonesian
28%
Jakarta
55%
Knowledge Attitude
23%
Knowledge Practices
15%
Magnetic Resonance Imaging
18%
Malignancy
16%
Meta-analysis of Randomized Controlled Trials
15%
Metastasis
17%
Myometrial Invasion
16%
Older Women
22%
Omental Metastasis
15%
Ovarian Cancer
44%
Ovarian Cancer Patients
22%
Ovarian Cancer Screening
15%
Ovarium
15%
Overall Survival
19%
Pada
15%
Papillomavirus Infections
15%
Patient-reported Outcomes
15%
Precancerous Lesions
16%
Prognostic Biomarker
16%
Radiotherapy
29%
Radiotherapy Response
24%
Risk Factors
18%
Risk of Malignancy Index
15%
Safety Self-efficacy
15%
Sustainable Development Goals
15%
Systematic Meta-analysis
23%
Urban Community
16%
Visual Inspection with Acetic Acid
23%
Medicine and Dentistry
Acetic Acid
23%
Age Distribution
9%
Biological Marker
18%
CA-125
48%
Cancer
54%
Cancer Registry
12%
Cancer Staging
16%
Cancer Stem Cell
15%
Cervical Cancer
99%
Cervix
10%
COVID-19
9%
Cross Sectional Study
31%
Cytoreductive Surgery
15%
Debulking Surgery
15%
Diffusion MRI
10%
Diseases
30%
Endometriosis
15%
Endometrium
10%
Female Genital Tract Cancer
29%
Gynecology
19%
Histopathology
23%
Human Tissue
15%
Immune Checkpoint Inhibitor
15%
Krukenberg Tumor
88%
Laparoscopic Surgery
10%
Magnetic Resonance Imaging
20%
Malignant Neoplasm
29%
Medicine
10%
Meta-Analysis
15%
Metastatic Carcinoma
33%
Neoplasm
38%
Neuroendocrine Carcinoma
15%
Ovarian Cancer
79%
Ovarian Tumor
32%
Overall Survival
11%
Patient-Reported Outcome
15%
Pelvis
14%
Precancerous Condition
17%
Prevalence
30%
Primary Health Care
19%
Prognostic Factor
10%
Radiation Therapy
40%
Randomized Controlled Trial
15%
Retrospective Study
22%
Squamous Cell Carcinoma
14%
Systematic Review
15%
Tissue Kallikrein
15%
Urban Population
15%
Uterine Cancer
25%
Uterine Cervix
15%